| 2021-03-08 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 25,000 0.0276% | $81.74 | $2.04M | -12.43% | |
| 2021-01-11 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 3,253 0.0034% | $110.81 | $360,477 | -31.03% | |
| 2021-01-08 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 6,229 0.0067% | $117.10 | $729,434 | -33.06% | |
| 2020-11-16 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 50,000 0.0562% | $51.83 | $2.59M | +56.34% | |
| 2020-09-14 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 50,000 0.0558% | $36.30 | $1.82M | +120.49% | |
| 2020-01-08 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 11,400 0.0141% | $20.70 | $235,972 | +51.02% | |
| 2019-12-30 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 50,000 0.0666% | $19.50 | $974,854 | +69.63% | |
| 2019-10-15 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 23,600 0.0302% | $14.29 | $337,185 | +95.66% | |
| 2019-06-27 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 25,000 0.0217% | $11.55 | $288,860 | +6.12% | |
| 2019-03-28 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 25,000 0.0223% | $9.92 | $247,953 | +9.67% | |
| 2017-10-16 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 1,400 0.0032% | $4.08 | $5,712 | +167.36% | |
| 2017-10-13 | Sale | Fate Therapeutics, Inc. FATE | Chief Scientific Officer | 25,050 0.0547% | $3.86 | $96,693 | +167.41% | |
| 2014-03-31 | Sale | Fate Therapeutics, Inc. FATE | Chief Technology Officer | 17,306 0.0856% | $9.86 | $170,722 | -46.46% |